Advancement of cetuximab combined with chemotherapy in the treatment of liver metastases from colorectal cancer / 肿瘤研究与临床
Cancer Research and Clinic
; (6): 501-504, 2010.
Article
in Zh
| WPRIM
| ID: wpr-383606
Responsible library:
WPRO
ABSTRACT
High incidence of liver metastases from colorectal cancer was found. To the patients with liver metastases from colorectal cancer, regardless of whether the liver metastases could be resected or not, hepatectomy after neoadjuvant chemotherapy was recommended. The combination of cetuximab and chemotherapy based on irinotecan and oxaliplatin as the second-line and first-line for the liver metastases from colorectal cancer could get higher response and longer survival, and more patients got the chance of hepatectomy. However, cetuximab was only good for the colorectal cancer patients with wild-type k-ras.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Cancer Research and Clinic
Year:
2010
Type:
Article